Skip to main content
. Author manuscript; available in PMC: 2018 Jan 11.
Published in final edited form as: Med Care. 2015 Apr;53(4 Suppl 1):S105–S111. doi: 10.1097/MLR.0000000000000271

TABLE 3.

Mental Health and Substance Use Disorder Treatment Access by Female Versus Male Veterans Seen by Veterans Justice Outreach Specialists in Fiscal Years 2010–2012

Women Men Access



Treatment n (%) M SD n (%) M SD AOR (95% CI)
Mental health disorder care*
  Outpatient visits 1324 (98) 36 40 22,430 (97) 30 37 1.19 (0.83–1.71)
  Inpatient days 241 (18) 13 18 4309 (19) 16 21 0.88 (0.76–1.02)
  Residential days 139 (10) 84 65 3106 (13) 86 70 0.69 (0.57–0.83)
Substance use disorder care
  Outpatient visits 637 (71) 31 33 15,279 (70) 31 36 1.05 (0.91–1.23)
  Residential days 109 (12) 42 35 2304 (11) 36 33 1.12 (0.90–1.39)
  Pharmacotherapy for alcohol use disorder 137 (22) 1823 (10) 2.24 (1.82–2.74)
  Pharmacotherapy for opioid use disorder§ 33 (18) 790 (20) 0.74 (0.50–1.10)
Other care
  Face-to-face visits 1535 (100) 55 60 30,478 (100) 49 59
  Primary care visits 1368 (89) 5 5 25,776 (85) 5 4 1.58 (1.34–1.87)

Mean/SD are reported only for veterans who received that type of care.

Values in bold indicate a statistically significant sex difference.

An odds ratio >1.00 indicates that women had higher odds of receiving that type of care than men.

An odds ratio <1.00 indicates that women had lower odds of receiving that type of care than men.

*

Limited to veterans who had a mental health diagnosis with the n (%) reporting the number of veterans who had at least 1 outpatient visit, or inpatient or residential day.

Limited to veterans who had a substance use disorder diagnosis with the n (%) reporting the number of veterans who had at least 1 outpatient visit or residential day.

Limited to veterans who had alcohol use disorder diagnosis with the percentage of veterans who received pharmacotherapy for alcohol use disorder reported.

§

Limited to veterans with an opioid use disorder diagnosis with the percentage of veterans who received pharmacotherapy for opioid use disorder reported.

AOR indicates adjusted odds ratio for receipt of at least 1 instance of that type of care for women versus men (reference); adjusted for age [< 25 y old (reference), 25–34, 35–44, 45–54, and 55+], race [American Indian/Alaskan Native, Asian, and black/African American, and white (reference)], ethnicity [Hispanic, non-Hispanic (reference)], marital status [single, married (reference), divorced/separated, and widowed], residence [rural, urban (reference)], homeless status [no (reference), yes], and service-connected disability rating [none (reference), <50%, ≥ 50%], and a random effect for facility (N = 128 medical centers).